Rakhee Ghosh, Corporate Communication at Biocon

Rakhee Ghosh

Corporate Communication at Biocon | Bengaluru, Karnataka, India

Profile last verified October 2026
Pharmaceuticals Verified Profile Bengaluru, Karnataka, India Symbiosis Centre for Distance Learning
Verified

Work Email

***@biocon.com

Last verified May 2026

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

(**) *** *** 345

India • Phone

Free account · No credit card · 5 profiles/month

Rakhee Ghosh Socials
Rakhee Ghosh Work Experience

Food & Travel Blogger at Google Maps in January 2022 - Present

Corporate Communication at Biocon in April 2023 - Present

Corporate Communication & PR at M3M India Private Limited in December 2021 - March 2023

See more See less

Quality Assurance (Internship) at DS Group in January 2021 - June 2021

Online course at SWAYAM MHRD in November 2020 - March 2021

Online Trainee at Indian Institute of Food Processing Technology (IIFPT) in October 2020 - October 2020

Winter Trainee at FICCI Research and Analysis Centre in December 2018 - January 2019

Rakhee Ghosh Education

Symbiosis Centre for Distance Learning, Post Graduation Diploma, November 2026

Sam Higginbottom University of Agriculture, Technology And Sciences (SHUATS), November 2026

Delhi Public School - India

Rakhee Ghosh Skills
Employee Engagement Leadership branding Newsletters Public Relations Corporate Communications Internal Communications Content Writing Designing Social Media Food Processing Project Management Food & Beverage Engineering Painting Writing Food Technology Microsoft Word Presentations Communication Public Speaking Problem Solving Decision-Making Teamwork Training Leadership English Food Preservation Market Penetration
About Rakhee Ghosh’s Current Company
Biocon

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars. The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products. We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders. Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five’ people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years. We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri™, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets. We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin. Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector. Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster’ drugs with the potential to benefit a billion patients.

Discover more about Biocon
Rakhee Ghosh’s Colleagues
Revathy Prathapan

Revathy Prathapan

Bengaluru, Karnataka, India

| R & D Intern at Biocon | Microbiologist | HACCP L3 | Food Safety Management for Manufacturing L4 | ISO 22000 : 2018 Awareness | FSSC 22000 V6 IA |

R&D Upstream Project Intern at Biocon
(July 2025 – Present)

Manrag Singh

Manrag Singh

Gurugram, Haryana, India

Assistant Manager and Motion Graphics Specialist - Group Communications at Biocon Group

Assistant Manager Global Communications at Biocon
(January 2024 – Present)

Shriyan Poovanna

Shriyan Poovanna

Bengaluru, Karnataka, India

Senior Scientist at Biocon | Biocon-KGI Certificate Program in Biosciences|JRF under DST Project at NITK Surathkal | MTech Biotechnology’24 NIT Warangal | NMAMIT Biotech’21

Senior Scientist at Biocon
(September 2025 – Present)

Shalini Srivastava

Shalini Srivastava

Bengaluru, Karnataka, India

Senior IT consultant ||Veeva QMS|| Medical Devices|| Trainer||SDEA || Lead Auditor-MD QMS ISO 13485-2016, ISO-9000, ISO-19011-2015|| Project Management

Senior Information Technology Consultant at Biocon
(October 2025 – Present)

Soumya Nyamagoudar

Soumya Nyamagoudar

Ahmedabad, Gujarat, India

Biocon Biologicals limited Bangalore||Intas pharmaceutical Ltd Ahamadabad

Internship Trainee at Biocon
(March 2025 – Present)

Project Management | TT-MSAT | API R&D | Bocon | VIT | BITS

Associate Manager at Biocon
(April 2023 – Present)

Search similar profiles
Frequently asked questions about Rakhee Ghosh

What is Rakhee Ghosh email address?

Email Rakhee Ghosh at [email protected], [email protected] and [email protected]. This email is the most updated Rakhee Ghosh's email found in 2026.

How to contact Rakhee Ghosh?

To contact Rakhee Ghosh send an email to [email protected], [email protected] or [email protected]. (updated on December 29, 2025)

What company does Rakhee Ghosh work for?

Rakhee Ghosh works for Biocon.

What is Rakhee Ghosh's role at Biocon?

Rakhee Ghosh is Corporate Communication

What industry does Rakhee Ghosh work in?

Rakhee Ghosh works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free